{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T23:55:00Z","timestamp":1769385300158,"version":"3.49.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023961","name":"Centro de Investigaci\u00f3n Biotecnol\u00f3gica en Red de Enfermedades Infecciosas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI143567"],"award-info":[{"award-number":["R01AI143567"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012866","name":"Cumming School of Medicine, University of Calgary","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Gobierno de Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-110275RB-I00"],"award-info":[{"award-number":["PID2019-110275RB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Gobierno de Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022-141317OB-I00"],"award-info":[{"award-number":["PID2022-141317OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bcp.2024.116512","type":"journal-article","created":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:52:13Z","timestamp":1725151933000},"page":"116512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Dasatinib interferes with HIV-1 proviral integration and the inflammatory potential of monocyte-derived macrophages from people with HIV"],"prefix":"10.1016","volume":"229","author":[{"given":"Sara","family":"Rodr\u00edguez-Mora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"S\u00e1nchez-Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiomar","family":"Bautista-Carrascosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Mateos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Moreno-Serna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Meg\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Cant\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valent\u00edn","family":"Garc\u00eda-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Ar\u00e1nzazu","family":"Murciano-Ant\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Cervero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Spivak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Planelles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayte","family":"Coiras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116512_b0005","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.chom.2020.03.014","article-title":"The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies","volume":"27","author":"Cohn","year":"2020","journal-title":"Cell Host Microbe."},{"key":"10.1016\/j.bcp.2024.116512_b0010","article-title":"The reservoir of latent HIV","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bcp.2024.116512_b0015","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.immuni.2018.04.030","article-title":"Targeting the Latent Reservoir for HIV-1","volume":"48","author":"Sengupta","year":"2018","journal-title":"Immunity."},{"key":"10.1016\/j.bcp.2024.116512_b0020","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.3389\/fmicb.2019.02828","article-title":"The Role of Macrophages in HIV-1 Persistence and Pathogenesis","volume":"10","author":"Kruize","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bcp.2024.116512_b0025","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/s41564-023-01349-3","article-title":"Monocyte-derived macrophages contain persistent latent HIV reservoirs","volume":"8","author":"Veenhuis","year":"2023","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.bcp.2024.116512_b0030","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.chom.2016.02.013","article-title":"Macrophages and HIV-1: An Unhealthy Constellation","volume":"19","author":"Sattentau","year":"2016","journal-title":"Cell Host Microbe."},{"key":"10.1016\/j.bcp.2024.116512_b0035","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nature10117","article-title":"SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx","volume":"474","author":"Laguette","year":"2011","journal-title":"Nature."},{"key":"10.1016\/j.bcp.2024.116512_b0040","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature10195","article-title":"Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein","volume":"474","author":"Hrecka","year":"2011","journal-title":"Nature."},{"key":"10.1016\/j.bcp.2024.116512_b0045","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nri1960","article-title":"Dendritic-cell interactions with HIV: infection and viral dissemination","volume":"6","author":"Wu","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2024.116512_b0050","doi-asserted-by":"crossref","first-page":"e1002425","DOI":"10.1371\/journal.ppat.1002425","article-title":"SAMHD1-deficient CD14+ cells from individuals with Aicardi-Gouti\u00e8res syndrome are highly susceptible to HIV-1 infection","volume":"7","author":"Berger","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bcp.2024.116512_b0055","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.celrep.2013.03.017","article-title":"Phosphorylation of SAMHD1 by cyclin A2\/CDK1 regulates its restriction activity toward HIV-1","volume":"3","author":"Cribier","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2024.116512_b0060","article-title":"Dasatinib: effects on the macrophage phospho proteome with a focus on SAMHD1 and HIV-1 infection","volume":"8","author":"Williams","year":"2022","journal-title":"Clin. Res. HIV\/AIDS."},{"key":"10.1016\/j.bcp.2024.116512_b0065","doi-asserted-by":"crossref","first-page":"e1010335","DOI":"10.1371\/journal.ppat.1010335","article-title":"HIV-1 cell-to-cell spread overcomes the virus entry block of non-macrophage-tropic strains in macrophages","volume":"18","author":"Han","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bcp.2024.116512_b0070","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.chom.2014.10.010","article-title":"Macrophage infection via selective capture of HIV-1-infected CD4+ T cells","volume":"16","author":"Baxter","year":"2014","journal-title":"Cell Host Microbe."},{"key":"10.1016\/j.bcp.2024.116512_b0075","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01237-17","article-title":"T Cell-Macrophage Fusion Triggers Multinucleated Giant Cell Formation for HIV-1 Spreading","volume":"91","author":"Bracq","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2024.116512_b0080","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1128\/JVI.02477-13","article-title":"Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities","volume":"88","author":"Joseph","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2024.116512_b0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11481-018-9795-4","article-title":"Host and Viral Factors Influencing Interplay between the Macrophage and HIV-1","volume":"14","author":"Machado Andrade","year":"2019","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bcp.2024.116512_b0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41590-018-0085-3","article-title":"Resistance of HIV-infected macrophages to CD8+ T lymphocyte-mediated killing drives activation of the immune system","volume":"19","author":"Clayton","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2024.116512_b0095","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1189\/jlb.0602325","article-title":"The many faces of macrophage activation","volume":"73","author":"Mosser","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2024.116512_b0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-6405-10-29","article-title":"Serious Non-AIDS events: Immunopathogenesis and interventional strategies","volume":"10","author":"Hsu","year":"2013","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.bcp.2024.116512_b0105","doi-asserted-by":"crossref","DOI":"10.1111\/imr.12065","article-title":"Immune Activation And Hiv Persistence: Implications For Curative Approaches To Hiv Infection","volume":"254","author":"Klatt","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bcp.2024.116512_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/v16020219","article-title":"Examining Chronic Inflammation, Immune Metabolism, and T Cell Dysfunction in HIV Infection","volume":"16","author":"Mu","year":"2024","journal-title":"Viruses."},{"key":"10.1016\/j.bcp.2024.116512_b0115","doi-asserted-by":"crossref","DOI":"10.1007\/s11481-018-9785-6","article-title":"HIV and the Macrophage: From Cell Reservoirs to Drug Delivery to Viral Eradication","volume":"14","author":"Herskovitz","year":"2019","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bcp.2024.116512_b0120","doi-asserted-by":"crossref","DOI":"10.1111\/hiv.12310","article-title":"Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy","volume":"17","author":"Younas","year":"2016","journal-title":"HIV Med."},{"key":"10.1016\/j.bcp.2024.116512_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114666","article-title":"Multidisciplinary Group of Study of HIV-1 Reservoir MGS-HIVRES, Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy","volume":"192","author":"Vig\u00f3n","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116512_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114203","article-title":"Cytotoxic cell populations developed during treatment with tyrosine kinase inhibitors protect autologous CD4+ T cells from HIV-1 infection","volume":"182","author":"Vig\u00f3n","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116512_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114816","article-title":"Pharmacologic control of homeostatic and antigen-driven proliferation to target HIV-1 persistence","volume":"194","author":"Innis","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116512_b0140","doi-asserted-by":"crossref","unstructured":"K. Lyseng-Williamson, B. Jarvis, Imatinib., Drugs. 61 (2001) 1765\u201374; discussion 1775-6. DOI: 10.2165\/00003495-200161120-00007.","DOI":"10.2165\/00003495-200161120-00007"},{"key":"10.1016\/j.bcp.2024.116512_b0145","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bcp.2016.02.002","article-title":"Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells","volume":"106","author":"Bermejo","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116512_b0150","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00819-18","article-title":"SAMHD1 Phosphorylation Coordinates the Anti-HIV-1 Response by Diverse Interferons and Tyrosine Kinase Inhibition","volume":"9","author":"Szaniawski","year":"2018","journal-title":"Mbio."},{"key":"10.1016\/j.bcp.2024.116512_b0155","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.celrep.2016.02.022","article-title":"IL-7 Induces SAMHD1 Phosphorylation in CD4+ T Lymphocytes, Improving Early Steps of HIV-1 Life Cycle","volume":"14","author":"Coiras","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2024.116512_b0160","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bcp.2018.08.031","article-title":"Evaluation of resistance to HIV-1 infection ex vivo of PBMCs isolated from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors","volume":"156","author":"Bermejo","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116512_b0165","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ebiom.2018.12.052","article-title":"Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study","volume":"40","author":"Justice","year":"2019","journal-title":"EBioMedicine."},{"key":"10.1016\/j.bcp.2024.116512_b0170","doi-asserted-by":"crossref","unstructured":"L.J. Hickson, L.G.P. Langhi Prata, S.A. Bobart, T.K. Evans, N. Giorgadze, S.K. Hashmi, S.M. Herrmann, M.D. Jensen, Q. Jia, K.L. Jordan, T.A. Kellogg, S. Khosla, D.M. Koerber, A.B. Lagnado, D.K. Lawson, N.K. LeBrasseur, L.O. Lerman, K.M. McDonald, T.J. McKenzie, J.F. Passos, R.J. Pignolo, T. Pirtskhalava, I.M. Saadiq, K.K. Schaefer, S.C. Textor, S.G. Victorelli, T.L. Volkman, A. Xue, M.A. Wentworth, E.O. Wissler Gerdes, Y. Zhu, T. Tchkonia, J.L. Kirkland, Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease., EBioMedicine. 47 (2019) 446\u2013456. DOI: 10.1016\/j.ebiom.2019.08.069.","DOI":"10.1016\/j.ebiom.2019.08.069"},{"key":"10.1016\/j.bcp.2024.116512_b0175","article-title":"Culture of macrophage colony-stimulating factor differentiated human monocyte-derived macrophages","volume":"2016","author":"Jin","year":"2016","journal-title":"J. vis. Exp."},{"key":"10.1016\/j.bcp.2024.116512_b0180","doi-asserted-by":"crossref","unstructured":"P. Colin, Z. Zhou, I. Staropoli, J. Garcia-Perez, R. Gasser, M. Armani-Tourret, Y. Benureau, N. Gonzalez, J. Jin, B.J. Connell, S. Raymond, P. Delobel, J. Izopet, H. Lortat-Jacob, J. Alcami, F. Arenzana-Seisdedos, A. Brelot, B. Lagane, CCR5 structural plasticity shapes HIV-1 phenotypic properties., PLoS Pathog. 14 (2018) e1007432. DOI: 10.1371\/journal.ppat.1007432.","DOI":"10.1371\/journal.ppat.1007432"},{"key":"10.1016\/j.bcp.2024.116512_b0185","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2008-07-168393","article-title":"Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells","volume":"113","author":"Bosque","year":"2009","journal-title":"Blood."},{"key":"10.1016\/j.bcp.2024.116512_b0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cell.2008.07.032","article-title":"Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication","volume":"135","author":"K\u00f6nig","year":"2008","journal-title":"Cell."},{"key":"10.1016\/j.bcp.2024.116512_b0195","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1084\/jem.164.1.280","article-title":"Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus","volume":"164","author":"Folks","year":"1986","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2024.116512_b0200","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/87979","article-title":"A quantitative assay for HIV DNA integration in vivo","volume":"7","author":"Butler","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2024.116512_b0205","doi-asserted-by":"crossref","first-page":"10119","DOI":"10.1128\/JVI.77.18.10119-10124.2003","article-title":"Analysis of Early Human Immunodeficiency Virus Type 1 DNA Synthesis by Use of a New Sensitive Assay for Quantifying Integrated Provirus","volume":"77","author":"Brussel","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2024.116512_b0210","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1128\/JVI.80.8.3712-3720.2006","article-title":"Evidence for a Functional Link between Uncoating of the Human Immunodeficiency Virus Type 1 Core and Nuclear Import of the Viral Preintegration Complex","volume":"80","author":"Dismuke","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2024.116512_b0215","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/mr.59.1.63-93.1995","article-title":"The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection","volume":"59","author":"Bour","year":"1995","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.bcp.2024.116512_b0220","doi-asserted-by":"crossref","first-page":"e0118722","DOI":"10.1128\/jvi.01187-22","article-title":"Sulforaphane Reduces SAMHD1 Phosphorylation To Protect Macrophages from HIV-1 Infection","volume":"96","author":"Sharifi","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2024.116512_b0225","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02457-19","article-title":"Cell-to-Cell Spreading of HIV-1 in Myeloid Target Cells Escapes SAMHD1 Restriction","volume":"10","author":"Xie","year":"2019","journal-title":"Mbio."},{"key":"10.1016\/j.bcp.2024.116512_b0230","doi-asserted-by":"crossref","DOI":"10.1038\/nm.2964","article-title":"SAMHD1 restricts HIV-1 infection in resting CD4 + T cells","volume":"18","author":"Baldauf","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2024.116512_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2010.06.019","article-title":"Comparison of potency assays using different read-out systems and their suitability for quality control","volume":"360","author":"Zumpe","year":"2010","journal-title":"J. Immunol. Methods."},{"key":"10.1016\/j.bcp.2024.116512_b0240","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jmv.20770","article-title":"A new strategy based on recombinant viruses as a tool for assessing drug susceptibility of human immunodeficiency virus type 1","volume":"79","author":"Garcia-Perez","year":"2007","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bcp.2024.116512_b0245","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20182009","article-title":"AP-1 activity induced by co-stimulation is required for chromatin opening during T cell activation","volume":"217","author":"Yukawa","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2024.116512_b0250","doi-asserted-by":"crossref","unstructured":"T.D. Saccon, R. Nagpal, H. Yadav, M.B. Cavalcante, A.D. de C. Nunes, A. Schneider, A. Gesing, B. Hughes, M. Yousefzadeh, T. Tchkonia, J.L. Kirkland, L.J. Niedernhofer, P.D. Robbins, M.M. Masternak, Senolytic Combination of Dasatinib and Quercetin Alleviates Intestinal Senescence and Inflammation and Modulates the Gut Microbiome in Aged Mice., J. Gerontol. A. Biol. Sci. Med. Sci. 76 (2021) 1895\u20131905. DOI: 10.1093\/gerona\/glab002.","DOI":"10.1093\/gerona\/glab002"},{"key":"10.1016\/j.bcp.2024.116512_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104357","article-title":"Dasatinib ameliorates chronic pancreatitis induced by caerulein via anti-fibrotic and anti-inflammatory mechanism","volume":"147","author":"Zeng","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2024.116512_b0260","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-015-1176-5","article-title":"CD14+ macrophages that accumulate in the colon of African AIDS patients express pro-inflammatory cytokines and are responsive to lipopolysaccharide","volume":"15","author":"Cassol","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.bcp.2024.116512_b0265","doi-asserted-by":"crossref","DOI":"10.1189\/jlb.1009673","article-title":"Macrophage polarization and HIV-1 infection","volume":"87","author":"Cassol","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2024.116512_b0270","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/317537","article-title":"Type 1\/Type 2 immunity in infectious diseases","volume":"32","author":"Spellberg","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bcp.2024.116512_b0275","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.exphem.2008.05.002","article-title":"Dasatinib exerts an immunosuppressive effect on CD8+ T cells specific for viral and leukemia antigens","volume":"36","author":"Fei","year":"2008","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bcp.2024.116512_b0280","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1042\/BJ20141165","article-title":"The clinically approved drugs dasatinib and bosutinib induce anti-inflammatory macrophages by inhibiting the salt-inducible kinases","volume":"465","author":"Ozanne","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2024.116512_b0285","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10787-013-0177-5","article-title":"The multiple faces of CCL13 in immunity and inflammation","volume":"21","author":"Mendez-Enriquez","year":"2013","journal-title":"Inflammopharmacology."},{"key":"10.1016\/j.bcp.2024.116512_b0290","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.4049\/jimmunol.157.12.5613","article-title":"Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3","volume":"157","author":"Garcia-Zepeda","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2024.116512_b0295","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jlb.62.5.620","article-title":"Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation","volume":"62","author":"Luster","year":"1997","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2024.116512_b0300","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.jaci.2018.04.013","article-title":"Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles","volume":"141","author":"Ghebre","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bcp.2024.116512_b0305","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jhep.2013.01.038","article-title":"Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function","volume":"58","author":"Du Plessis","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2024.116512_b0310","doi-asserted-by":"crossref","unstructured":"A.M. Al -Ameri, H. Kantarjian, E. Burton, S. O\u2019Brien, F. Ravandi, G. Borthakur, B. Walker, M.B. Rios, J. Cortes, Low Risk of Infectious Events in Patients (Pts) with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) Treated with Dasatinib., Blood. 114 (2009) 3291\u20133291. DOI: 10.1182\/blood.V114.22.3291.3291.","DOI":"10.1182\/blood.V114.22.3291.3291"},{"key":"10.1016\/j.bcp.2024.116512_b0315","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1182\/blood.V114.22.1120.1120","article-title":"Opportunistic Infections Are Uncommon with Dasatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)","volume":"114","author":"Al-Ameri","year":"2009","journal-title":"Blood."},{"key":"10.1016\/j.bcp.2024.116512_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113625","article-title":"Dasatinib protects humanized mice from acute HIV-1 infection","volume":"174","author":"Salgado","year":"2020","journal-title":"Biochem. Pharmacol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224004957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224004957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T17:17:10Z","timestamp":1741713430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224004957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":64,"alternative-id":["S0006295224004957"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116512","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dasatinib interferes with HIV-1 proviral integration and the inflammatory potential of monocyte-derived macrophages from people with HIV","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116512"}}